Half cell solar panels, which divide conventional full-sized cells into two electrically independent halves, have moved from ...

Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...

With Cellares preparing to begin commercial-stage production in 2027, the California-based cell therapy contract manufacturer has taken a major step toward that goal, ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a $257 million Series D financing co--led by investment funds managed by BlackRock and Eclipse, ...

No country has affected global solar panel supply chains more than the United States. Since the boom of solar in the early ...

Management continues to anticipate the presentation of three-year OpRegen trial data in June 2025, with Culley expressing hope it will “provide additional conviction in our approach.” There remains no ...